Pericapsular Exparel for Pain Relief in Bunionectomy and Related Procedures

Summary

Exparel is an FDA-approved local anesthetic (bupivacaine), in a long-release formulation. In this study the investigators plan to determine the ability of Exparel to control post-operative pain in common first metatarsophalangeal (MTP) joint procedures (bunion surgery, 1st MTP fusion, and cheilectomy).

Timeline

Start

2015-07

Primary completion

2016-01

Completion

2016-07

Outcome

Outcome not reported

Stopped (Enrollment): “Logistical issues prevent efficient enrollment”

Drugs

Indications